首页> 外文期刊>Journal of cellular biochemistry. >Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
【24h】

Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.

机译:槲皮素通过Sp1介导的DR5上调和蛋白酶体介导的c-FLIPS下调使人肝癌细胞对TRAIL诱导的凋亡敏感。

获取原文
获取原文并翻译 | 示例
           

摘要

This study demonstrates that combined treatment with subtoxic doses of quercetin (3',3',4',5,7-pentahydroxyflavone), a flavonoid found in many fruits and vegetables, plus tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rapid apoptosis in TRAIL-resistant hepatocellular carcinoma (HCC) cells. Effective induction of apoptosis by the combined treatment with quercetin and TRAIL was not blocked by overexpression of Bcl-xL, which is known to confer resistance to various chemotherapeutic agents. These results suggest that this combined treatment may provide an attractive strategy for treating resistant HCCs. While the proteolytic processing of procaspase-3 by TRAIL was partially blocked in various HCC cells treated with TRAIL alone, co-treatment with quercetin efficiently recovered TRAIL-induced caspase activation. We found that quercetin treatment of HCC cells significantly up-regulated the mRNA and protein levels of DR5, a death receptor of TRAIL, in a transcription factor Sp1-dependent manner. Furthermore, treatment with quercetin significantly decreased the protein levels of c-FLIP, an inhibitor of caspase-8, through proteasome-mediated degradation. Finally, administration of small interfering RNA against DR5 or overexpression of c-FLIPS, but not c-FLIPL, significantly attenuated quercetin-stimulated TRAIL-induced apoptosis. Collectively, these findings show that quercetin recovers TRAIL sensitivity in various HCC cells via up-regulation of DR5 and down-regulation of c-FLIPS.
机译:这项研究表明,联合治疗与亚毒性剂量的槲皮素(3',3',4',5,7-五羟基黄酮),许多水果和蔬菜中存在的类黄酮以及肿瘤坏死因子相关的凋亡诱导配体(TRAIL)联合治疗诱导TRAIL耐药的肝细胞癌(HCC)细胞中的快速凋亡。槲皮素和TRAIL联合治疗有效诱导细胞凋亡不会被Bcl-xL的过表达所阻断,Bcl-xL的表达可赋予多种化学治疗药物以抗性。这些结果表明,这种联合治疗可能为治疗耐药性HCC提供有吸引力的策略。虽然在单独用TRAIL处理的各种HCC细胞中TRAIL对procaspase-3的蛋白水解过程被部分阻断,但与槲皮素的共处理有效地恢复了TRAIL诱导的caspase活化。我们发现槲皮素治疗HCC细胞以转录因子Sp1依赖性方式显着上调TRAIL的死亡受体DR5的mRNA和蛋白质水平。此外,用槲皮素治疗可通过蛋白酶体介导的降解显着降低caspase-8抑制剂c-FLIP的蛋白水平。最后,抗DR5的小干扰RNA或c-FLIPS(而非c-FLIPL)的过表达显着减弱了槲皮素刺激的TRAIL诱导的细胞凋亡。这些发现共同表明,槲皮素通过上调DR5和下调c-FLIPS恢复各种HCC细胞的TRAIL敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号